NovaBiotics at World Antimicrobial Resistance Congress, Washington

Date posted: 13/09/2017

NovaBiotics’ Chief Executive Deborah O’Neil has been invited to join the keynote panel on the second day of this year’s World Antimicrobial Resistance Congress in Washington. Deborah will be joining other panellists at 09.40am on Friday 15th September to discuss ‘Driving the Direction and Future of Antibiotic Companies While Fostering Continuous Investments’.

World Antimicrobial Resistance Congress aims to address change from both the scientific and economic sides of antimicrobial resistance. The conference will see leaders from each area brought together in one place to take steps toward finding collaborative solutions to tackle the global AMR threat.

Please find further information on World Antimicrobial Resistance Congress here.